Design and Development of PLGA and Polysaccharide Microparticles
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 25 April 2026
Special Issue Editors
Interests: mucoadhesion; drug delivery systems; polymeric systems; nanotechnology; oral delivery
Special Issues, Collections and Topics in MDPI journals
Interests: mucoadhesion; targeted delivery; lipid-based nanocarriers; drug delivery systems; polymeric systems; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The design and development of PLGA (poly(lactic-co-glycolic acid)) and polysaccharide-based microparticles represent a promising strategy in the field of controlled drug delivery systems. Due to its biocompatibility and biodegradability, PLGA allows for the formation of stable particles capable of protecting and gradually releasing active ingredients. Polysaccharides, such as chitosan, alginate, and dextran, can be used alone or in combination with PLGA to modulate physicochemical properties such as hydrophilicity, mucoadhesion, and permeability. Combining these polymers allows for the adjustment of the release profile, the greater stability of the encapsulated drug, and specific targeting, expanding therapeutic applications in different biomedical areas. Recognizing the importance of these drug delivery systems in the pharmaceutical field, we invite you to contribute a short communication, research article, or review article to this Special Issue, entitled “Design and Development of PLGA and Polysaccharide Microparticles.” This Special Issue will publish articles describing the design and development of ligand-targeted microparticles for the active targeting of therapeutic agents.
Dr. Suzana Gonçalves Carvalho
Dr. Marlus Chorilli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery systems
- polymeric systems
- nanotechnology
- controlled release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
